Jan 11, 2021 / 01:20PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Alnylam. And speaking on behalf of the company, we have CEO, John Maraganore. Before I turn it over to John, I just wanted to highlight for those listeners on the webcast to feel free to submit a question via the ask-a-question feature in the portal. John?
John M. Maraganore - Alnylam Pharmaceuticals, Inc. - CEO & Executive Director
Thanks, Anupam. It's great to be here. It's especially great to put 2020 and even this past week behind us now and to be in 2021.
Despite last year's adversities, Alnylam actually had one of its strongest years ever. And I'm so proud of our Alnylam employees who persevered with their challenge-accepted spirit and a commitment to the patients we serve. For example, we started 2020 with 2 products, 6
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers